| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 176.252 | 82 |
| GSM780708 | Untreated after 4 days (C2_1) | 194.559 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 185.758 | 83 |
| GSM780719 | Untreated after 4 days (C1_2) | 151.192 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 212.352 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 197.182 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 229.362 | 85 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 162.369 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 181.842 | 83 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 194.233 | 83 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 157.375 | 81 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 202.541 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 150.332 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 170.338 | 82 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 141.059 | 80 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 148.456 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 170.125 | 82 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 146.709 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 160.217 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 144.927 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 163.105 | 81 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 163.331 | 81 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 177.254 | 82 |